Page last updated: 2024-10-31

methylphenidate and Briquet Syndrome

methylphenidate has been researched along with Briquet Syndrome in 7 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research Excerpts

ExcerptRelevanceReference
" Statistical comparisons of specific somatic complaints indicated minimal agreement between parents and children in contrast to the nearly identical parent-child dose-response curves."2.70Attention-Deficit/Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints. ( Moffitt, C; Randall, R; Rapport, MD, 2002)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's6 (85.71)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyers, BJ1
van Ojen, RL1
Rikkert, MG1
Geurts, AC1
Lem, FC1
Rashid, J1
Mitelman, S1
Vigano, A1
Watanabe, S1
Bruera, E1
Phillips, KA1
Albertini, RS1
Siniscalchi, JM1
Khan, A1
Robinson, M1
Rapport, MD1
Randall, R1
Moffitt, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Parallel-group, Double-blind, Placebo-controlled Study of Methylphenidate as an Add on Therapy for Mirtazapine in the Treatment of Major Depressive Disorder in Cancer Patients Under Palliative Care[NCT01497548]Phase 3120 participants (Anticipated)Interventional2011-03-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for methylphenidate and Briquet Syndrome

ArticleYear
Attention-Deficit/Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints.
    Journal of attention disorders, 2002, Volume: 6, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over

2002

Other Studies

6 other studies available for methylphenidate and Briquet Syndrome

ArticleYear
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
    Nederlands tijdschrift voor geneeskunde, 2004, Aug-28, Volume: 148, Issue:35

    Topics: Adult; Aged; Central Nervous System Stimulants; Delirium; Depression; Female; Humans; Lymphoma, B-Ce

2004
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
    Nederlands tijdschrift voor geneeskunde, 2004, Nov-27, Volume: 148, Issue:48

    Topics: Central Nervous System Stimulants; Clinical Trials as Topic; Delirium; Depression; Diagnosis, Differ

2004
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
    Nederlands tijdschrift voor geneeskunde, 2004, Nov-27, Volume: 148, Issue:48

    Topics: Central Nervous System Stimulants; Delirium; Depression; Humans; Methylphenidate; Somatoform Disorde

2004
Methylphenidate and somatic hallucinations.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2007, Volume: 46, Issue:8

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Hallucinati

2007
Methylphenidate for the management of somatization in terminal cancer patients.
    Journal of pain and symptom management, 1995, Volume: 10, Issue:2

    Topics: Humans; Male; Methylphenidate; Middle Aged; Prostatic Neoplasms; Somatoform Disorders; Terminal Care

1995
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:9

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Buspirone; Child; Drug Administ

2001